Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress.

de Souza, Veruska Cintia Alexandrino

Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress. [electronic resource] - World journal of gastroenterology Jul 2017 - 5146-5157 p. digital

Publication Type: Journal Article

2219-2840

10.3748/wjg.v23.i28.5146 doi


Actins--metabolism
Animals
CD11b Antigen--metabolism
Carbon Tetrachloride--toxicity
Cell Separation
Cell- and Tissue-Based Therapy--methods
Cytokines--metabolism
Disease Models, Animal
Enzyme-Linked Immunosorbent Assay
Ethanol--toxicity
Flow Cytometry
Glutathione--metabolism
Humans
Immunohistochemistry
Lipopolysaccharide Receptors--metabolism
Liver--metabolism
Liver Cirrhosis--chemically induced
Male
Mice
Mice, Inbred C57BL
Monocytes--metabolism
Osteopontin--metabolism
Oxidative Stress